Oura’s May 2026 confidential IPO filing and $11 billion post-Series E valuation from the $900 million October 2025 round anchor trader expectations near the $10–12.5 billion bracket. Rapid revenue expansion—projected above $1 billion for 2025 and $1.5 billion for 2026, with subscriptions comprising 20 percent—supports higher multiples versus historical wearables precedents like Fitbit. Closely matched probabilities across $7.5–20 billion+ ranges reflect uncertainty over final IPO pricing amid 2026 market conditions, competitive positioning in health tech, and potential valuation step-ups or discounts relative to the latest private round.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano$10B–$12.5B 14%
$20B+ 14%
$15B–$17.5B 13%
No IPO before January 2027 11.8%
$176,416 Wol.
$176,416 Wol.
Jan 1, 2027
<$7.5B
8%
$7.5B–$10B
11%
$10B–$12.5B
14%
$12.5B–$15B
11%
$15B–$17.5B
13%
$17.5B–$20B
12%
$20B+
14%
No IPO before January 2027
12%
$10B–$12.5B 14%
$20B+ 14%
$15B–$17.5B 13%
No IPO before January 2027 11.8%
$176,416 Wol.
$176,416 Wol.
Jan 1, 2027
<$7.5B
$19,089 Wol.
8%
$7.5B–$10B
$27,547 Wol.
11%
$10B–$12.5B
$22,365 Wol.
14%
$12.5B–$15B
$50,617 Wol.
11%
$15B–$17.5B
$13,822 Wol.
13%
$17.5B–$20B
$16,938 Wol.
12%
$20B+
$20,600 Wol.
14%
No IPO before January 2027
$5,438 Wol.
12%
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.Oura’s May 2026 confidential IPO filing and $11 billion post-Series E valuation from the $900 million October 2025 round anchor trader expectations near the $10–12.5 billion bracket. Rapid revenue expansion—projected above $1 billion for 2025 and $1.5 billion for 2026, with subscriptions comprising 20 percent—supports higher multiples versus historical wearables precedents like Fitbit. Closely matched probabilities across $7.5–20 billion+ ranges reflect uncertainty over final IPO pricing amid 2026 market conditions, competitive positioning in health tech, and potential valuation step-ups or discounts relative to the latest private round.
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Rynek otwarty: May 26, 2026, 12:28 PM ET
Wolumen
$176,416Data zakończenia
Jan 1, 2027Rynek otwarty
May 26, 2026, 12:28 PM ETResolver
0x69c47De9D...This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.Oura’s May 2026 confidential IPO filing and $11 billion post-Series E valuation from the $900 million October 2025 round anchor trader expectations near the $10–12.5 billion bracket. Rapid revenue expansion—projected above $1 billion for 2025 and $1.5 billion for 2026, with subscriptions comprising 20 percent—supports higher multiples versus historical wearables precedents like Fitbit. Closely matched probabilities across $7.5–20 billion+ ranges reflect uncertainty over final IPO pricing amid 2026 market conditions, competitive positioning in health tech, and potential valuation step-ups or discounts relative to the latest private round.
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Wolumen
$176,416Data zakończenia
Jan 1, 2027Rynek otwarty
May 26, 2026, 12:28 PM ETResolver
0x69c47De9D...Oura’s May 2026 confidential IPO filing and $11 billion post-Series E valuation from the $900 million October 2025 round anchor trader expectations near the $10–12.5 billion bracket. Rapid revenue expansion—projected above $1 billion for 2025 and $1.5 billion for 2026, with subscriptions comprising 20 percent—supports higher multiples versus historical wearables precedents like Fitbit. Closely matched probabilities across $7.5–20 billion+ ranges reflect uncertainty over final IPO pricing amid 2026 market conditions, competitive positioning in health tech, and potential valuation step-ups or discounts relative to the latest private round.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania